Table 2 Summary of indicators for HIV Testing at first presentation
| Â | All n = 165 | 1995-2000 n = 48 | 2004-2009 n = 117 | Pvalue |
|---|---|---|---|---|
Summary | Â | Â | Â | Â |
   Median no. clinical indicators | 1 (0-2) | 1 (1-2) | 1 (0-1) | 0.002 |
   Median number of all non-clinical indicators | 2 (1-2) | 1 (1-2) | 2 (1-3) | < 0.001 |
   Median number of all clinical & non-clinical indicators | 3 (2-4) | 3 (2-4) | 3 (2-4) | 0.697 |
Services indicator (any) | 102 (62%) | 19 (40%) | 83 (71%) | < 0.001 |
   Ante-natal/ToP | 14 (9%) | 4 (8%) | 10 (9%) | 0.964 |
   GUM | 61 (37%) | 8 (17%) | 53 (45%) | 0.001 |
   TB, Hep B/C, lymphoma | 27 (16%) | 8 (17%) | 19 (16%) | 0.964 |
   Occupational health or screening* | 11 (7%) | 3 (6%) | 8 (7%) | 0.891 |
Transmission risk indicator (any) | 132 (80%) | 33 (69%) | 99 (85%) | 0.021 |
   Country of origin high prevalence (> 1%) | 53 (32%) | 10 (21%) | 43 (37%) | 0.047 |
   Men with disclosed sexual contact with men (MSM) | 46 (28%) | 14 (29%) | 32 (27%) | 0.813 |
   IVDU | 8 (5%) | 2 (4%) | 6 (5%) | 0.794 |
   Sexual contact abroad | 42 (26%) | 10 (21%) | 32 (28%) | 0.383 |
   Partner HIV+ | 24 (15%) | 6 (13%) | 18 (15%) | 0.633 |
   Blood donors, dialysis patients or organ donors/recipients | 6 (4%) | 4 (8%) | 2 (2%) | 0.039 |
Non-clinical indicator (any transmission risk or service indicator) | 147 (89%) | 37 (77%) | 110 (94%) | 0.002 |
Clinical Indicator diseases (any) | 119 (72%) | 42 (88%) | 74 (63%) | 0.005 |